CARA Systems, an NYU spinout, uses AI-driven imaging and patient-specific analytics to help neurospecialists make more consistent, individualized decisions about intracranial aneurysm risk.
SAN MATEO, Calif.--(BUSINESS WIRE)--RapidAI, the global leader in neurovascular and vascular AI-enhanced clinical decision support and patient workflow, today announced it has received FDA clearance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results